EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.99 Million EUR | -58.44% |
| 2022 | 4.8 Million EUR | -23.03% |
| 2021 | 6.24 Million EUR | 123.46% |
| 2020 | 2.79 Million EUR | -16.19% |
| 2019 | 3.33 Million EUR | 52.26% |
| 2018 | 2.19 Million EUR | 60.87% |
| 2017 | 1.36 Million EUR | 95.41% |
| 2016 | 697 Thousand EUR | -21.33% |
| 2015 | 886 Thousand EUR | 27.12% |
| 2014 | 697 Thousand EUR | 12.97% |
| 2013 | 617 Thousand EUR | -88.41% |
| 2012 | 5.32 Million EUR | 276.33% |
| 2011 | 1.41 Million EUR | -85.49% |
| 2010 | 9.75 Million EUR | -8.9% |
| 2009 | 10.7 Million EUR | 3.26% |
| 2008 | 10.36 Million EUR | -18.69% |
| 2007 | 12.74 Million EUR | 1588.91% |
| 2006 | 754.65 Thousand EUR | 42.78% |
| 2005 | 528.53 Thousand EUR | -20.21% |
| 2004 | 662.43 Thousand EUR | 12.89% |
| 2003 | 586.78 Thousand EUR | 515.75% |
| 2002 | 95.29 Thousand EUR | -82.15% |
| 2001 | 533.85 Thousand EUR | -84.69% |
| 2000 | 3.48 Million EUR | -45.18% |
| 1999 | 6.36 Million EUR | 14.79% |
| 1998 | 5.54 Million EUR | 258.62% |
| 1997 | 1.54 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.25 Million EUR | -22.52% |
| 2024 Q1 | 1.62 Million EUR | -18.83% |
| 2023 Q2 | 3.55 Million EUR | -16.56% |
| 2023 FY | 1.99 Million EUR | -58.44% |
| 2023 Q4 | 1.99 Million EUR | -46.99% |
| 2023 Q1 | 4.25 Million USD | -11.48% |
| 2023 Q3 | 3.77 Million EUR | 6.14% |
| 2022 FY | 4.8 Million EUR | -23.03% |
| 2022 Q4 | 4.8 Million EUR | -14.19% |
| 2022 Q2 | 5.81 Million EUR | -4.81% |
| 2022 Q1 | 6.11 Million EUR | -2.19% |
| 2022 Q3 | 5.6 Million EUR | -3.66% |
| 2021 Q1 | 2.83 Million EUR | 1.43% |
| 2021 FY | 6.24 Million EUR | 123.46% |
| 2021 Q2 | 6.63 Million EUR | 133.78% |
| 2021 Q4 | 6.24 Million EUR | -4.73% |
| 2021 Q3 | 6.55 Million EUR | -1.09% |
| 2020 FY | 2.79 Million EUR | -16.19% |
| 2020 Q4 | 2.79 Million EUR | -4.99% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | - EUR | 0.0% |
| 2020 Q3 | 2.94 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | - EUR | 0.0% |
| 2019 FY | 3.33 Million EUR | 52.26% |
| 2019 Q4 | 3.33 Million EUR | 0.0% |
| 2019 Q3 | - EUR | 0.0% |
| 2018 Q2 | 1.65 Million EUR | 0.0% |
| 2018 FY | 2.19 Million EUR | 60.87% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q4 | 2.19 Million EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2017 FY | 1.36 Million EUR | 95.41% |
| 2017 Q3 | - EUR | -100.0% |
| 2017 Q4 | 1.36 Million EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q2 | 597 Thousand EUR | 0.0% |
| 2016 Q2 | 719 Thousand EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 FY | 697 Thousand EUR | -21.33% |
| 2016 Q4 | 697 Thousand EUR | 0.0% |
| 2016 Q3 | - EUR | -100.0% |
| 2015 Q3 | - EUR | -100.0% |
| 2015 Q4 | 886 Thousand EUR | 0.0% |
| 2015 Q1 | - EUR | -100.0% |
| 2015 FY | 886 Thousand EUR | 27.12% |
| 2015 Q2 | 574 Thousand EUR | 0.0% |
| 2014 Q1 | - EUR | -100.0% |
| 2014 Q4 | 697 Thousand EUR | 0.0% |
| 2014 FY | 697 Thousand EUR | 12.97% |
| 2014 Q3 | - EUR | -100.0% |
| 2014 Q2 | 786 Thousand EUR | 0.0% |
| 2013 Q2 | 780 Thousand EUR | 0.0% |
| 2013 FY | 617 Thousand EUR | -88.41% |
| 2013 Q4 | 617 Thousand EUR | 0.0% |
| 2013 Q3 | - EUR | -100.0% |
| 2013 Q1 | - EUR | -100.0% |
| 2012 Q3 | - EUR | -100.0% |
| 2012 Q2 | 1.13 Million EUR | 0.0% |
| 2012 FY | 5.32 Million EUR | 276.33% |
| 2012 Q4 | 5.32 Million EUR | 0.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2011 Q1 | - EUR | -100.0% |
| 2011 Q2 | 8.2 Million EUR | 0.0% |
| 2011 Q3 | - EUR | -100.0% |
| 2011 Q4 | 1.41 Million EUR | 0.0% |
| 2011 FY | 1.41 Million EUR | -85.49% |
| 2010 Q2 | 11.75 Million EUR | 0.0% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 FY | 9.75 Million EUR | -8.9% |
| 2010 Q4 | 9.75 Million EUR | 0.0% |
| 2009 FY | 10.7 Million EUR | 3.26% |
| 2009 Q3 | - EUR | -100.0% |
| 2009 Q1 | - EUR | -100.0% |
| 2009 Q2 | 11.14 Million EUR | 0.0% |
| 2009 Q4 | 10.7 Million EUR | 0.0% |
| 2008 FY | 10.36 Million EUR | -18.69% |
| 2008 Q2 | 9.83 Million EUR | 0.0% |
| 2008 Q3 | - EUR | -100.0% |
| 2008 Q4 | 10.36 Million EUR | 0.0% |
| 2007 Q4 | 12.74 Million EUR | 1006.32% |
| 2007 FY | 12.74 Million EUR | 1588.91% |
| 2007 Q3 | 1.15 Million EUR | 0.0% |
| 2006 Q1 | - EUR | -100.0% |
| 2006 Q3 | - EUR | -100.0% |
| 2006 Q2 | 795.12 Thousand EUR | 0.0% |
| 2006 FY | 754.65 Thousand EUR | 42.78% |
| 2006 Q4 | 754.65 Thousand EUR | 0.0% |
| 2005 Q2 | - EUR | 0.0% |
| 2005 Q4 | 528.53 Thousand EUR | 0.0% |
| 2005 Q1 | - EUR | -100.0% |
| 2005 FY | 528.53 Thousand EUR | -20.21% |
| 2004 Q2 | - EUR | 0.0% |
| 2004 FY | 662.43 Thousand EUR | 12.89% |
| 2004 Q3 | - EUR | 0.0% |
| 2004 Q4 | 662.43 Thousand EUR | 0.0% |
| 2004 Q1 | - EUR | -100.0% |
| 2003 Q2 | - EUR | 0.0% |
| 2003 Q3 | - EUR | 0.0% |
| 2003 Q4 | 586.78 Thousand EUR | 0.0% |
| 2003 Q1 | - EUR | -100.0% |
| 2003 FY | 586.78 Thousand EUR | 515.75% |
| 2002 Q2 | - EUR | 0.0% |
| 2002 FY | 95.29 Thousand EUR | -82.15% |
| 2002 Q3 | - EUR | 0.0% |
| 2002 Q4 | 95.29 Thousand EUR | 0.0% |
| 2002 Q1 | - EUR | -100.0% |
| 2001 Q3 | - EUR | -100.0% |
| 2001 Q1 | 3.13 Million EUR | -10.27% |
| 2001 Q2 | 430 Thousand EUR | -86.26% |
| 2001 Q4 | 533.85 Thousand EUR | 0.0% |
| 2001 FY | 533.85 Thousand EUR | -84.69% |
| 2000 FY | 3.48 Million EUR | -45.18% |
| 2000 Q2 | 5.53 Million EUR | -7.99% |
| 2000 Q3 | 5.41 Million EUR | -2.17% |
| 2000 Q4 | 3.48 Million EUR | -35.53% |
| 2000 Q1 | 6.01 Million EUR | -5.54% |
| 1999 Q4 | 6.36 Million EUR | 0.0% |
| 1999 FY | 6.36 Million EUR | 14.79% |
| 1998 FY | 5.54 Million EUR | 258.62% |
| 1998 Q4 | 5.54 Million EUR | 0.0% |
| 1997 FY | 1.54 Million EUR | 0.0% |
| 1997 Q4 | 1.54 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.609% |
| Nemaura Medical Inc. | 3.08 Million USD | 35.27% |
| NeuroPace, Inc. | 56.95 Million USD | 96.491% |
| LENSAR, Inc. | 1.75 Million USD | -14.208% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 67.836% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -60.663% |
| Apyx Medical Corporation | 33.18 Million USD | 93.977% |
| Cutera, Inc. | 418.69 Million USD | 99.523% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 86.715% |
| BioSig Technologies, Inc. | 103 Thousand USD | -1840.433% |
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 94.464% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.865% |
| Axonics, Inc. | 25.84 Million USD | 92.265% |
| IRIDEX Corporation | 1.75 Million USD | -14.143% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 96.107% |
| TELA Bio, Inc. | 40.51 Million USD | 95.067% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -1035.594% |
| RxSight, Inc. | 1.21 Million USD | -65.041% |
| Align Technology, Inc. | 96.96 Million USD | 97.939% |
| INVO Bioscience, Inc. | 6.77 Million USD | 70.504% |
| electroCore, Inc. | 537 Thousand USD | -272.187% |
| Telesis Bio, Inc. | 5.26 Million USD | 62.068% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 66.529% |
| Quipt Home Medical Corp. | 60.82 Million USD | 96.714% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 92.571% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -239.906% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -904.345% |
| Dynatronics Corporation | 3.25 Million USD | 38.663% |
| Modular Medical, Inc. | 817 Thousand USD | -144.632% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -1223.607% |
| Talis Biomedical Corporation | 16.78 Million USD | 88.093% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -96.537% |
| InMode Ltd. | 6.61 Million USD | 69.777% |
| Envoy Medical, Inc. | 404 Thousand USD | -394.714% |
| Bruker Corporation | 1.14 Billion USD | 99.825% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -16555.383% |
| DexCom, Inc. | 2.57 Billion USD | 99.922% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| PAVmed Inc | 2.96 Million USD | 32.478% |
| Viveve Medical, Inc. | 5.12 Million USD | 60.994% |
| Cerus Corporation | 59.79 Million USD | 96.658% |
| Movano Inc. | 15.00 USD | -13324206.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 88.973% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| IceCure Medical Ltd | 376 Thousand USD | -431.555% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.499% |
| enVVeno Medical Corporation | 1.06 Million USD | -87.843% |
| 908 Devices Inc. | 3.92 Million USD | 49.131% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 79.911% |
| Orthofix Medical Inc. | 93.1 Million USD | 97.853% |
| Surmodics, Inc. | 29.4 Million USD | 93.203% |
| Nuwellis, Inc. | 221 Thousand USD | -804.365% |
| Outset Medical, Inc. | 134.59 Million USD | 98.515% |
| Venus Concept Inc. | 70.79 Million USD | 97.177% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 94.281% |
| Treace Medical Concepts, Inc. | 53 Million USD | 96.23% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 50.59% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -207.602% |
| Inogen, Inc. | 18.27 Million USD | 89.061% |
| IRadimed Corporation | 1.61 Million USD | -23.749% |
| MaxCyte, Inc. | 17.96 Million USD | 88.877% |
| Pulmonx Corporation | 35.08 Million USD | 94.304% |
| PAVmed Inc. | 2.96 Million USD | 32.478% |
| iCAD, Inc. | 273 Thousand USD | -632.105% |
| OrthoPediatrics Corp. | 13.45 Million USD | 85.15% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -449.495% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -3515.234% |
| SI-BONE, Inc. | 36.06 Million USD | 94.458% |
| Semler Scientific, Inc. | 70 Thousand USD | -2755.209% |
| Beyond Air, Inc. | 14.72 Million USD | 86.423% |
| FONAR Corporation | 37.92 Million USD | 94.731% |
| AxoGen, Inc. | 46.6 Million USD | 95.711% |
| Biotricity, Inc. | 10.85 Million USD | 81.589% |
| Cytosorbents Corporation | 2.54 Million USD | 21.402% |
| ZimVie Inc. | 508.79 Million USD | 99.607% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 95.52% |
| Inari Medical, Inc. | 30.35 Million USD | 93.416% |
| UFP Technologies, Inc. | 28 Million USD | 92.862% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Sight Sciences, Inc. | 31.7 Million USD | 93.697% |
| Insulet Corporation | 1.36 Billion USD | 99.854% |
| Profound Medical Corp. | 4.97 Million USD | 59.822% |
| Bioventus Inc. | 366.99 Million USD | 99.455% |
| InspireMD, Inc. | 1.03 Million USD | -92.548% |
| BrainsWay Ltd. | 239 Thousand USD | -736.254% |
| BIOLASE, Inc. | 13.98 Million USD | 85.709% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -360.47% |
| Tenon Medical, Inc. | 428 Thousand USD | -366.973% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -99.466% |
| CVRx, Inc. | 30.38 Million USD | 93.422% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.905% |
| Sintx Technologies, Inc. | 3.68 Million USD | 45.792% |
| Acutus Medical, Inc. | 32.65 Million USD | 93.879% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -31.403% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 94.631% |
| LivaNova PLC | 568.54 Million USD | 99.648% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 7.134% |
| Varex Imaging Corporation | 464.2 Million USD | 99.569% |
| Vivani Medical, Inc. | 19.31 Million USD | 89.651% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -239.906% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -235.343% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.776% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.605% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -229.266% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -2061.049% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Hyperfine, Inc. | 64 Thousand USD | -3022.884% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 98.941% |
| Biomerica, Inc. | 459 Thousand USD | -335.435% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -344.654% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -951.991% |
| Silk Road Medical, Inc | 75.62 Million USD | 97.357% |